B-HT 920, 55
B-HT 933, 56
BE 2254, 57
β receptor, 58
β2-adrenoceptor
gene, 59
β2-adrenoceptor
haplotypes, 60
β2-adrenoceptor
polymorphisms, 61, 62
β2-adrenoceptor
structure, 63
β2-adrenoceptor
variants, 64
betaxolol, 65
bisoprolol, 66
blue dextran, 67
brachydactyly, 68, 69
bromophenol blue, 70
BUP, 71
Caerphilly Prospective Heart Study, 72
cAMP, 73
candidate gene, 74, 75
catechol O-methyl transferase, 76
catecholamine, 77, 78
release of, 79
Centrifuges, 80
CGP 20712A, 81
cholinergic receptor, 82
cirazoline, 83
complex trait, 84
contamination, 85
corticotrophin, 86
cycle sequencing, 87
BigDye terminator, 88, 89
dye primer, 90, 91
Dahl salt-sensitive rat, 92
denaturing gradient gel electrophoresis, 93
deoxynucleotide triphosphate, 94, 95
deproteinisation, 96
desensitisation, 97
DGGE, see denaturing gradient gel electrophoresis
diabetes, 99
discordant sibling pair analysis, 100
DNA
double-stranded, 101
heat denaturation, 102
precipitation, 103
single-stranded, 104, 105
DNA preparation, see nucleic acid preparation
dopamine, 107, 108
dyes
dRhodamine, 109
fluorescein, 110
rhodamine, 111
electrophoresis
systems, 112
enalapril, 113
epinephrine, 114, 115, 116, 117, 118
ethanol precipitation, 119
ethidium bromide, 120, 121, 122
ethylenediamine tetraacetic acid, 123
5-FAM, 124
fenoterol, 125
Formamide, 126
G-protein, 127, 128, 129, 130, 131
gene loci, 132
Glucocorticoid-Remediable Aldosteronism, 133
gluconeogenesis, 134
glycogen, 135
glycogenolysis, 136
glycosylation, 137, 138
glycosylation site, 139, 140
Gordon’s Syndrome, 141
high blood pressure, 142
8-hydroxyquinoline, 143
hypertension
environmental factors, 144
essential, 145, 146
primary, 147
secondary, 148
hypoglycemia, 149
hypothermia, 150
hypoxia, 151
ICI 118, 152
ICI 551, 153
isoamyl alcohol, 154
JOE, 155
Liddle’s syndrome, 156
Light measurement, 157
linkage disequilibrium, 158
lipolysis, 159
melting temperature, 160
membrane spanning domains, 161, 162
β-mercaptoethanol, 163
methoxamine, 164
α-methyl-arterenone, 165
N,N’-methylenebisacrylamide, 166
metoprolol, 167
monoamine oxidase, 168
mRNA, 169
MULLIS, 170
multifactorial disease, 171
neurotransmitter, 172
nonparametric linkage, 173
norepinephrine, 174, 175, 176, 177
L(–)-norepinephrine, 178
nucleic acid
precipitate, 179
preparation, 180
quantification, 181
oligonucleotide, 182
purification, 183
quantification, 184
synthesis, 185
palmitoylisation, 186
PASA, see polymerase allele-specific amplification
PCR, 188, 189, 190, 191–192
buffer, 193
cloning, 194
cross-contamination, 195
fidelity, 196
nested, 197
primers, 198
specifity, 199
phenol, 200
extraction, 201
phenylephrine, 202
phosphorylation site, 203
Plasticware, 204
polyacrylamide gel, 205–206
polymerase allele-specific amplification, 207
polymerase chain reaction, see PCR
practolol, 209
prazosin, 210
preganglionic axon, 211
primer, 212
primer dimer, 213, 214
primers
dye-labelled, 215
procaterol, 216
promoter, 217
Proteinase K, 218
pyrophosphatase, 219
pyrophosphate, 220
pyrophosphorolysis, 221
radioligand assays, 222
RAS, 223
rauwolscine, 224
receptor sequestration, 225
Refrigeration, 226
renin, 227
rhodopsin, 228
RNase A mismatch, 229
ROX, 230
RX 781094, 231
salbutamol, 232, 233, 234
second messenger, 235
sequencing, 236
dideoxy method, 237
fluorescent, 238
Sevac, 239, 240
SHR, see spontaneously hypertensive rat
single strand conformation polymorphism, 242
Sodium dodecyl sulfate, 243
spectrophotometer, 244
spontaneously hypertensive rat, 245
SSCP, see single strand conformation polymorphism
stroke, 247
sympathetic nervous system, 248
syndrome of apparent mineralocorticoid excess, 249
TAE buffer, 250
TAMRA, 251
Taq-polymerase, 252, 253, 254
TBE buffer, 255
TEMED, 256
template denaturation, 257
terazosin, 258
terbutaline, 259
terminators
dye-labelled, 260
N,N,N’,N’-tetramethylenediamine, 261
thiazide diuretics, 262
Tm, 263, 264
triamterene, 265
twin studies, 266
vasoconstriction, 269
vasodilatation, 270
white coat hypertension, 271
xylene cyanol, 272
yohimbine, 273
© 2001 Alexander Binder